GlassScriptPhysician profile
Maribeth Bobeldyke
NPI 1396828364
$3,065.26
in general payments reported to CMS, 2019-2025
38 companies · $881 in 2025
The $881 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $570 · 2023: $580 · 2024: $733 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $419.18 | 2022-2025 | Farxiga, Airsupra, Xigduo |
| Pfizer INC. | $301.99 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $238.49 | 2022-2025 | Rexulti |
| Novo Nordisk INC | $202.59 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Daiichi Sankyo INC. | $131.92 | 2021-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $119.79 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.57 | 2022-2025 | Xifaxan |
| Lilly USA, LLC | $83.62 | 2022-2025 | Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $46.91 | 2022-2025 | |
| Abbott Laboratories | $42.20 | 2023-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $40.81 | 2022 | |
| Sumitomo Pharma America, INC. | $38.38 | 2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $35.91 | 2022 | |
| Mayne Pharma Commercial LLC | $35.43 | 2023-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maribeth Bobeldyke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.